← Back to Search

Self-Administered Hypnosis for Mild Cognitive Impairment

N/A
Waitlist Available
Research Sponsored by Baylor University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week during baseline week
Awards & highlights

Study Summary

This trialwill test if hypnosis could help people with mild cognitive impairment (MCI) sleep better. 20 participants will practice hypnosis for 7 weeks, and researchers will measure the success and feasibility of the intervention.

Eligible Conditions
  • Mild Cognitive Impairment
  • Insomnia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 7 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 7 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attitudes Toward Hypnosis Scale
Daily At-home Self-Hypnosis Practice Log
Daily Sleep Diaries
+6 more
Secondary outcome measures
Insomnia Severity Index
Motivation Scale
PROMIS Cognitive Function - Short Form
+2 more
Other outcome measures
Post-Participation Interview

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Self-Administered HypnosisExperimental Treatment1 Intervention
Participants randomized to the self-administered hypnosis group will receive five audio-recordings of self-administered hypnosis, specifically targeting sleep improvement, which they will use for daily home practice.
Group II: White Noise Hypnosis ControlActive Control1 Intervention
Participants randomized to the white noise hypnosis control will receive the same information and contact with the therapist but will be provided with audio recordings that contain white noise as a sham hypnosis condition. These recordings include instructions and the use of white noise as a hypnotic induction.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Self-Administered Hypnosis
2018
N/A
~290

Find a Location

Who is running the clinical trial?

Baylor UniversityLead Sponsor
55 Previous Clinical Trials
65,129 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
831 Previous Clinical Trials
668,910 Total Patients Enrolled

Media Library

Self-Administered Hypnosis Clinical Trial Eligibility Overview. Trial Name: NCT05215717 — N/A
Mild Cognitive Impairment Research Study Groups: Self-Administered Hypnosis, White Noise Hypnosis Control
Mild Cognitive Impairment Clinical Trial 2023: Self-Administered Hypnosis Highlights & Side Effects. Trial Name: NCT05215717 — N/A
Self-Administered Hypnosis 2023 Treatment Timeline for Medical Study. Trial Name: NCT05215717 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Hypnosis for Sleep Quality for Individuals With Mild Cognitive Impairment
Gary R. Elkins 2022. "Hypnosis for Sleep Quality for Individuals With Mild Cognitive Impairment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05215717.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top